We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 413

CMS considers linking Medicare drug payment rates to international prices
  • Hogan Lovells
  • USA
  • October 30 2018

On October 25, 2018, the Centers for Medicare & Medicaid Services (CMS) issued an Advance Notice of Proposed Rulemaking (ANPRM) describing a potential


Trump touts “historic” plan to overhaul Medicare payments, create International Pricing Index
  • Hogan Lovells
  • USA
  • October 25 2018

President Trump today touted “bold” plans to lower drug prices in unspecific terms. Simultaneously, CMS issued an Advance Notice of Proposed


FDA schedules public hearing on solutions to drug shortages
  • Hogan Lovells
  • USA
  • October 8 2018

FDA schedules public hearing on solutions to drug shortages October 08, 2018 The U.S. Food and Drug Administration (FDA) has announced it will hold a


HHS watchdog eyes anti-kickback safe harbors for care coordination, beneficiary incentives, and cost-sharing
  • Hogan Lovells
  • USA
  • August 29 2018

On Monday, the Department of Health and Human Services (HHS) Office of the Inspector General (OIG) published a wide-ranging Request for Information


New Jersey Issues Rules to Chill Drug Manufacturer Payments to Prescribers
  • Hogan Lovells
  • USA
  • January 10 2018

The New Jersey Attorney General plans to finalize new limits on payments and other benefits that New Jersey licensed prescribers may accept from


FDA finalizes 3D printing guidance
  • Hogan Lovells
  • USA
  • December 20 2017

On December 5, 2017, the U.S. Food and Drug Administration (FDA or the Agency) finalized its "leapfrog guidance" entitled, "Technical


CAMD released roadmap concerning the priorities for the implementation of the MDR and IVDR
  • Hogan Lovells
  • European Union
  • November 23 2017

The Competent Authorities for Medical Devices (“CAMD”) has published a roadmap concerning the implementation of the Medical Devices Regulation (“MDR”)


Sugar tax
  • Hogan Lovells
  • South Africa
  • November 21 2017

SARS has issued for comment by no later than 30 November 2017 draft rules relating to the health promotion levy imposed on sugary beverages


New California Law Limits Drug Manufacturer Co-Pay Cards and Other Discounts in California
  • Hogan Lovells
  • USA
  • October 16 2017

In the most recent salvo by states eager to show an effort to contain prescription drug costs, California's governor has signed into law a bill that


European Commission adopted legal acts to improve Good Manufacturing Practices for medicinal products
  • Hogan Lovells
  • European Union
  • October 5 2017

On 15 September 2017, the European Commission adopted two legal acts intended to update good manufacturing practice (“GMP”) requirements for